Literature DB >> 18071318

In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin.

F Bourdeaut1, A Ribeiro, R Paris, G Pierron, J Couturier, M Peuchmaur, O Delattre.   

Abstract

Neuroblastic tumours are composed of variable proportions of neuroblasts and Schwann cells. Whether both components share a common neoplastic origin is highly debated and discrepant results have been reported about the presence of tumour-related genetic alterations in Schwann cells. We have used X-methylation analysis and array-CGH to investigate contiguous Schwannian and neuroblastic areas in tumours with a nodular pattern. A skewed X inactivation was observed in four out of five stromal components. Interestingly, in these four cases, the X-inactivation profiles of the neuroblastic components were identical to the matched stromal areas. However, whereas all neuroblastic areas displayed chromosomal imbalances, no alteration was found in any Schwann cell components. Similarly, no alteration was observed in a series of 19 tumours with a single stroma-rich component, which occasionally exhibited a skewed X-inactivation pattern (3/17 informative tumours). Altogether, this indicates that most stroma-rich tumours display a polyclonal proliferation and that Schwann cells do not derive from neuroblasts. However, in tumours with both stroma-rich and -poor components, our results suggest that cells from both areas share a common progenitor.

Entities:  

Mesh:

Year:  2007        PMID: 18071318     DOI: 10.1038/sj.onc.1210965

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Authors:  Caroline Masserot; Qingyuan Liu; Eric Nguyen; Charles-Henry Gattolliat; Dominique Valteau-Couanet; Jean Bénard; Catherine Huber; Evelyne Ségal-Bendirdjian
Journal:  Mol Oncol       Date:  2015-10-21       Impact factor: 6.603

Review 2.  Schwann cells: a new player in the tumor microenvironment.

Authors:  Yuri L Bunimovich; Anton A Keskinov; Galina V Shurin; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2016-11-24       Impact factor: 6.968

3.  Tissue-resident glial cells associate with tumoral vasculature and promote cancer progression.

Authors:  Beatriz G S Rocha; Caroline C Picoli; Bryan O P Gonçalves; Walison N Silva; Alinne C Costa; Michele M Moraes; Pedro A C Costa; Gabryella S P Santos; Milla R Almeida; Luciana M Silva; Youvika Singh; Marcelo Falchetti; Gabriela D A Guardia; Pedro P G Guimarães; Remo C Russo; Rodrigo R Resende; Mauro C X Pinto; Jaime H Amorim; Vasco A C Azevedo; Alexandre Kanashiro; Helder I Nakaya; Edroaldo L Rocha; Pedro A F Galante; Akiva Mintz; Paul S Frenette; Alexander Birbrair
Journal:  Angiogenesis       Date:  2022-10-01       Impact factor: 10.658

4.  Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.

Authors:  Sandra Acosta; Cinzia Lavarino; Raquel Paris; Idoia Garcia; Carmen de Torres; Eva Rodríguez; Helena Beleta; Jaume Mora
Journal:  BMC Dev Biol       Date:  2009-02-12       Impact factor: 1.978

5.  The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.

Authors:  Paola Angelini; Sylvain Baruchel; Paula Marrano; Meredith S Irwin; Paul S Thorner
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

6.  Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression.

Authors:  Mayumi Nagashimada; Hiroshi Ohta; Chong Li; Kazuki Nakao; Toshihiro Uesaka; Jean-François Brunet; Jeanne Amiel; Delphine Trochet; Teruhiko Wakayama; Hideki Enomoto
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

Review 7.  The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.

Authors:  Nancy Ratner; Garrett M Brodeur; Russell C Dale; Nina F Schor
Journal:  Ann Neurol       Date:  2016-04-30       Impact factor: 10.422

8.  Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.

Authors:  V Veschi; M Petroni; A Bartolazzi; P Altavista; C Dominici; C Capalbo; R Boldrini; A Castellano; H P McDowell; B Pizer; L Frati; I Screpanti; A Gulino; G Giannini
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

9.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Authors:  P F Ambros; I M Ambros; G M Brodeur; M Haber; J Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; S L Cohn; A D J Pearson; J M Maris
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics.

Authors:  Inge M Ambros; Clemens Brunner; Reza Abbasi; Christian Frech; Peter F Ambros
Journal:  Front Oncol       Date:  2014-08-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.